Lorem ipsum dolor sit amet, consectetur adipiscing elit,
A First-In-Human Study of OTO-413, an Intratympanic Sustained-Exposure Formulation of BDNF, for the Treatment of Speech-in-Noise Hearing Impairment Jeffery J. Anderson(1), James Robinson(1), Alice Blaj(1), Ines Hoffmann(1), Alan Foster(1),
View More Are you a woman living with schizophrenia? We have several clinical trials that might be just right for you. The trials are compensated if you qualify, and transportation is
View More [et_pb_section fb_built=”1″ _builder_version=”3.0.47″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.0.47″][et_pb_text _builder_version=”3.21″] SALT LAKE CITY, Dec. 5, 2019 /PRNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Research Centers
View More [et_pb_section fb_built=”1″ _builder_version=”3.0.47″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.0.47″][et_pb_text _builder_version=”3.21″] SALT LAKE CITY, Sept. 23, 2019 /PRNewswire/ — CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announced that Todd
View More [et_pb_section fb_built=”1″ _builder_version=”3.0.47″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.0.47″][et_pb_text _builder_version=”3.21″] SALT LAKE CITY and ANAHEIM, Calif., Sept. 9, 2019 /PRNewswire/ — CenExel Clinical Research, Inc., (“CenExel” or the “Company”)
View More [et_pb_section fb_built=”1″ _builder_version=”3.21″ custom_padding=”0|0px|54px|0px|false|false”][et_pb_row _builder_version=”3.21″][et_pb_column type=”4_4″ _builder_version=”3.21″][et_pb_text _builder_version=”3.21″] Salt Lake City, Utah – July 18, 2019 – CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announces the creation of
View More [et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.7.1″] Esketamine, a drug developed by Johnson & Johnson for the treatment of depression has received support from two
View More Depression treatment Gaithersburg. If you are experiencing depression and no medications have really helped, maybe one of our trials will.
View More
